Phase I, Randomized, Rater and Participant Blinded Placebo-Controlled Study of the Safety, Reactogenicity, Tolerability and Immunogenicity of H1N1 Influenza Vaccine Delivered by VX-103 (a MIMIX Microneedle Patch [MAP] System) in Healthy Adults

Investigators described safety, reactogenicity, tolerability and immunogenicity for MIMIX microneedle array patch vaccination against influenza.
[PLOS One]
Full Article